Skip to main content
Clinical Trials/NCT00800657
NCT00800657UnknownPhase 1

Stem-Cells and Heart Failure in Several Ethiologies. Alternative Indication With Cardiac Resynchronization

Instituto de Molestias Cardiovasculares2 sites in 1 country30 target enrollmentStarted: November 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Sponsor
Enrollment
30
Locations
2
Primary Endpoint
Ejection Fraction(EF)-(Eco- Sympson):It is the comparison of these measurements between late pre and post operative. NYHA: Comparison of these measurements between late pre and post operative.

Study Overview

Brief Summary

Same patients with dilated myocardiopathies with large areas of fibrosis has not been as successful after Cardiac Resynchronization Therapy, for Heart Failure patients in functional class III or IV. Therefore the investigators have decided to associate the Stem-Cell implant with Cardiac Resynchronization Therapy in these patients.

Detailed Description

About 120cc of blood are collected from the iliac bone marrow under epidural anesthesia.In the cell therapy lab this blood is harvested and mononuclear cells are separated.This procedure takes roughly 4 hours.After dilution the mononuclear cells are injected into the cardiac muscles with fibroses area through 20 shots.This procedure is indicated for patients with cardiac ischemia and left ventricular dysfunction(desynchrony), on whom all the others known therapies have failed.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Dilated Cardiomyopathy
  • Heart Failure
  • Optimized Therapeutics
  • Ventricular Desynchrony
  • Functional Class III or IV
  • Ejection Fraction(Echo/ Sympson) < 35%

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Ejection Fraction(EF)-(Eco- Sympson):It is the comparison of these measurements between late pre and post operative. NYHA: Comparison of these measurements between late pre and post operative.

Time Frame: 24 months

Secondary Outcomes

  • Ejection Fraction (Echo/Sympson) and functional class(NYHA).(24 months.)

Investigators

Sponsor
Instituto de Molestias Cardiovasculares
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials